Prot# SPO-0012: Phase 1b Open-Label, Multicenter, Dose-Escalating, Clinical Study of the Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Profiles of SNS-595 Injection in Combination With Cytarabine in Patients With Relapsed or Refractory Ac

  • Tallman, Martin Stuart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/22/09 → 7/31/10

Funding

  • Sunesis Pharmaceuticals, Inc. (SPO-0012)